Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
Many neurogenetic disorders are caused by the mutation of ubiquitously expressed genes. One such disorder, spinal muscular atrophy, is caused by loss or mutation of the survival motor neuron1 gene (SMN1), leading to reduced SMN protein levels and a selective dysfunction of motor neurons. SMN, together with partner proteins, functions in the assembly of small nuclear ribonucleoproteins (snRNPs), which are important for pre-mRNA splicing. It has also been suggested that SMN might function in the assembly of other ribonucleoprotein complexes. Two hypotheses have been proposed to explain the molecular dysfunction that gives rise to spinal muscular atrophy (SMA) and its specificity to a particular group of neurons. The first hypothesis states that the loss of SMN's well-known function in snRNP assembly causes an alteration in the splicing of a specific gene (or genes). The second hypothesis proposes that SMN is crucial for the transport of mRNA in neurons and that disruption of this function results in SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also of particular relevance is the possible role of HuD in spinal muscular atrophy (SMA), a disease that results in degeneration of spinal cord motor neurons due to deletion or loss-of-function mutations in the survival of motor neuron 1 (SMN1) gene, resulting in inadequate expression of functional SMN protein (Burghes and Beattie 2009).”
From Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction (2013) · cites this paper as Burghes and Beattie 2009
Experimental — accuracy not yet measuredIn the citing paper
“SMA is a devastating neurodegenerative disease resulting from progressive loss of motor neurons.1”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107 · cited 1×
“cgi?id=105400">amyotrophic lateral sclerosis (caused by mutations in superoxide dismutase 1 ( SOD1 )”
BackgroundCorrelation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
Self-citationNon-coding RNAs: lessons from the small nuclear and small nucleolar RNAs
Matera, A. G., Terns, R. M., & Terns, M. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2124 · Cited by 877
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
Cited by
Items 101–200 of 825
Saal, L., Briese, M., Kneitz, S., Glinka, M., & Sendtner, M. (2014) · RNA · doi:10.1261/rna.047373.114 · Cited by 96
RNA-targeted splice-correction therapy for neuromuscular disease
Wood, M. J. A., Gait, M. J., & Yin, H. (2010) · Brain · doi:10.1093/brain/awq002 · Cited by 111
Cabanas, E. D., Hereu, M., Piedrafita, L., Casanovas, A., Calderó, J., & Esquerda, J. E. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31821cbd8b · Cited by 110
Drug treatment for spinal muscular atrophy types II and III
Wadman, R. I., Bosboom, W. M., van der Pol, W. L., van den Berg, L. H., Wokke, J. H. J., Iannaccone, S. T., & Vrancken, A. F. J. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006282.pub4 · Cited by 109
Tisdale, S., Lotti, F., Saieva, L., Meerbeke, J. P. V., Crawford, T. O., Sumner, C. J., Mentis, G. Z., & Pellizzoni, L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.012 · Cited by 108
Vascular D efects and S pinal C ord H ypoxia in S pinal M uscular A trophy
Somers, E., Lees, R. D., Hoban, K., Sleigh, J. N., Zhou, H., Muntoni, F., Talbot, K., Gillingwater, T. H., & Parson, S. H. (2015) · Annals of Neurology · doi:10.1002/ana.24549 · Cited by 108
SMN and Gemins: ‘We are family’ … or are we?
Cauchi, R. J. (2010) · BioEssays · doi:10.1002/bies.201000088 · Cited by 108
AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
Pattali, R. K., Mou, Y., & Li, X.-J. (2019) · Gene Therapy · doi:10.1038/s41434-019-0085-4 · Cited by 107
Fallini, C., Rouanet, J. P., Donlin-Asp, P., Guo, P., Zhang, H., Singer, R. H., Rossoll, W., & Bassell, G. J. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22111 · Cited by 106
The neurobiology of amyotrophic lateral sclerosis
Bento‐Abreu, A., Van Damme, P., Van Den Bosch, L., & Robberecht, W. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07260.x · Cited by 85
Passini, M. A., Bu, J., Richards, A. M., Treleaven, C. M., Sullivan, J. A., O'Riordan, C. R., Scaria, A., Kells, A. P., Samaranch, L., San Sebastian, W., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.011 · Cited by 93
The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?
Hensel, N., & Claus, P. (2017) · The Neuroscientist · doi:10.1177/1073858417705059 · Cited by 104
Yoshida, M., Kitaoka, S., Egawa, N., Yamane, M., Ikeda, R., Tsukita, K., Amano, N., Watanabe, A., Morimoto, M., Takahashi, J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.010 · Cited by 102
“Since there are no effective treatment options, SMA remains the most frequent genetic cause of infant mortality (Burghes and Beattie, 2009; Lefebvre et al., 1995).”
BackgroundChang, T., Zheng, W., Tsark, W., Bates, S., Huang, H., Lin, R.-J., & Yee, J.-K. (2011) · Stem Cells · doi:10.1002/stem.749 · Cited by 92
Gray, J. M., Harmin, D. A., Boswell, S. A., Cloonan, N., Mullen, T. E., Ling, J. J., Miller, N., Kuersten, S., Ma, Y.-C., McCarroll, S. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089673 · Cited by 96
Torres‐Benito, L., Neher, M. F. M., Cano, R., Ruiz, R., & Tabares, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026164 · Cited by 101
Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials
Nurputra, D. K., Lai, P. S., Harahap, N. I. F., Morikawa, S., Yamamoto, T., Nishimura, N., Kubo, Y., Takeuchi, A., Saito, T., Takeshima, Y., et al. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12031 · Cited by 100
Developments in RNA Splicing and Disease
Poulos, M. G., Batra, R., Charizanis, K., & Swanson, M. S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000778 · Cited by 98
“In addition to SMN, this ATP-dependent SMN “assemblyosome” complex consists of several GEMINS (SIP1/GEMIN2, DDX20/ GEMIN3, GEMINS4-8) and STRAP/UNRIP (Paushkin et al. 2002; Burghes and Beattie 2009).”
BackgroundInfluentialSMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy
Lauria, F., Bernabò, P., Tebaldi, T., Groen, E. J. N., Perenthaler, E., Maniscalco, F., Rossi, A., Donzel, D., Clamer, M., Marchioretto, M., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00577-7 · Cited by 98
The COPI vesicle complex binds and moves with survival motor neuron within axons
Peter, C. J., Evans, M., Thayanithy, V., Taniguchi-Ishigaki, N., Bach, I., Kolpak, A., Bassell, G. J., Rossoll, W., Lorson, C. L., Bao, Z., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr046 · Cited by 98
A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2
Jodelka, F. M., Ebert, A. D., Duelli, D. M., & Hastings, M. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq425 · Cited by 98
Woo, C. J., Maier, V., Davey, R., Brennan, J., Li, G., Brothers, J. F., Schwartz, B. E., Gordo, S., Kasper, A., Okamoto, T. R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616521114 · Cited by 97
Ruhno, C., McGovern, V. L., Avenarius, M. R., Snyder, P. J., Prior, T. W., Nery, F. C., Muhtaseb, A. W., Roggenbuck, J., Kissel, J. T., Sansone, V., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-01983-0 · Cited by 97
Self-citationReliable Generation of Induced Pluripotent Stem Cells From Human Lymphoblastoid Cell Lines
Barrett, R. J., Ornelas, L., Yeager, N., Mandefro, B., Sahabian, A., Lenaeus, L., Targan, S. R., Svendsen, C. N., & Sareen, D. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0121 · Cited by 97
A screen for regulators of survival of motor neuron protein levels
Makhortova, N. R., Hayhurst, M., Cerqueira, A., Sinor-Anderson, A. D., Zhao, W.-N., Heiser, P. W., Arvanites, A. C., Davidow, L. S., Waldon, Z. O., Steen, J. A., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.595 · Cited by 87
How Parkinson's disease meets nucleolar stress
Parlato, R., & Liss, B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.014 · Cited by 96
Fallini, C., Bassell, G. J., & Rossoll, W. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-17 · Cited by 78
Spinal muscular atrophy: Development and implementation of potential treatments
Arnold, W. D., & Burghes, A. H. M. (2013) · Annals of Neurology · doi:10.1002/ana.23995 · Cited by 95
Self-citationMyogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy
Boyer, J. G., Deguise, M., Murray, L. M., Yazdani, A., Repentigny, Y. D., Boudreau‐Larivière, C., & Kothary, R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu142 · Cited by 95
Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy
Porensky, P. N., & Burghes, A. H. M. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.225 · Cited by 88
Self-citationRNA metabolism and the pathogenesis of motor neuron diseases
Lemmens, R., Moore, M. J., Al‐Chalabi, A., Brown, R. H., & Robberecht, W. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.02.003 · Cited by 92
Kannan, A., Bhatia, K., Branzei, D., & Gangwani, L. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky641 · Cited by 91
Hammond, S. M., Gogliotti, R. G., Rao, V. K., Beauvais, A., Kothary, R., & DiDonato, C. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015887 · Cited by 91
Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
Ahmad, S., Bhatia, K., Kannan, A., & Gangwani, L. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s33122 · Cited by 91
The Survival of Motor Neuron Protein Acts as a Molecular Chaperone for mRNP Assembly
Donlin-Asp, P., Fallini, C., Campos, J., Chou, C., Merritt, M. E., Phan, H. C., Bassell, G. J., & Rossoll, W. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.059 · Cited by 90
See, K., Yadav, P., Giegerich, M., Cheong, P. S., Graf, M. R., Vyas, H., Lee, S. G. P., Mathavan, S., Fischer, U., Sendtner, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt567 · Cited by 90
SMN in spinal muscular atrophy and snRNP biogenesis
Coady, T. H., & Lorson, C. L. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.76 · Cited by 89
Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy
Michaud, M., Arnoux, T., Bielli, S., Durand, E., Rotrou, Y., Jablonka, S., Robert, F., Giraudon‐Paoli, M., Rießland, M., Mattéi, M., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.006 · Cited by 88
A role for the survival of motor neuron protein in mRNP assembly and transport
Donlin-Asp, P., Bassell, G. J., & Rossoll, W. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.04.004 · Cited by 86
Diaper, D. C., Adachi, Y., Lazarou, L., Greenstein, M., Simoes, F. A., di Domenico, A., Solomon, D. A., Lowe, S. A., AlSubaie, R., Cheng, D., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt243 · Cited by 86
Survival Motor Neuron Affects Plastin 3 Protein Levels Leading to Motor Defects
Hao, L. T., Wolman, M. A., Granato, M., & Beattie, C. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5808-11.2012 · Cited by 85
Self-citationNeuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
Boido, M., & Vercelli, A. (2016) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2016.00006 · Cited by 85
A U1 snRNP–specific assembly pathway reveals the SMN complex as a versatile hub for RNP exchange
So, B. R., Wan, L., Zhang, Z., Li, P., Babiash, E. S., Duan, J., Younis, I., & Dreyfuss, G. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3167 · Cited by 85
Kissel, J. T., Elsheikh, B., King, W. M., Freimer, M. L., Scott, C., Kolb, S. J., Reyna, S. P., Crawford, T. O., Simard, L. R., Krosschell, K. J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23904 · Cited by 84
Mitrpant, C., Porensky, P., Zhou, H., Price, L., Muntoni, F., Fletcher, S., Wilton, S. D., & Burghes, A. H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062114 · Cited by 72
Self-citationSleigh, J. N., Barreiro-Iglesias, A., Oliver, P. L., Biba, A., Becker, T., Davies, K. E., Becker, C. G., & Talbot, K. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt477 · Cited by 65
Fuller, H. R., Mandefro, B., Shirran, S. L., Gross, A. R., Kaus, A. S., Botting, C. H., Morris, G. E., & Sareen, D. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00506 · Cited by 83
Survival Motor Neuron (SMN) protein is required for normal mouse liver development
Szunyogová, E., Zhou, H., Maxwell, G. K., Powis, R. A., Muntoni, F., Gillingwater, T. H., & Parson, S. H. (2016) · Scientific Reports · doi:10.1038/srep34635 · Cited by 83
Alstyne, M. V., Simon, C. M., Sardi, S. P., Shihabuddin, L. S., Mentis, G. Z., & Pellizzoni, L. (2018) · Genes & Development · doi:10.1101/gad.316059.118 · Cited by 83
The Survival Motor Neuron Protein Forms Soluble Glycine Zipper Oligomers
Martin, R. S., Gupta, K., Ninan, N. S., Perry, K., & Duyne, G. D. V. (2012) · Structure · doi:10.1016/j.str.2012.08.024 · Cited by 82
Electrophysiological biomarkers in spinal muscular atrophy: proof of concept
Arnold, W. D., Porensky, P. N., McGovern, V. L., Iyer, C. C., Duqué, S. I., Li, X., Meyer, K., Schmelzer, L., Kaspar, B. K., Kolb, S. J., et al. (2013) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.23 · Cited by 81
Self-citationDecreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis
Ishihara, T., Ariizumi, Y., Shiga, A., Kato, T., Tan, C., Sato, T., Miki, Y., Yokoo, M., Fujino, T., Koyama, A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt262 · Cited by 81
Praveen, K., Wen, Y., & Matera, A. G. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.05.014 · Cited by 81
Sleigh, J. N., Buckingham, S. D., Esmaeili, B., Viswanathan, M., Cuppen, E. P. J. G., Westlund, B., & Sattelle, D. B. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq459 · Cited by 81
Riancho, J., Gonzalo, I., Ruiz‐Soto, M., & Berciano, J. (2016) · Neurología · doi:10.1016/j.nrl.2015.12.001 · Cited by 81
mRNA Localization: An Orchestration of Assembly, Traffic and Synthesis
Xing, L., & Bassell, G. J. (2013) · Traffic · doi:10.1111/tra.12004 · Cited by 62
Antisense Oligonucleotide-Based Therapies for Diseases Caused by pre-mRNA Processing Defects
Rigo, F., Seth, P. P., & Bennett, C. F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_9 · Cited by 80
Simone, C., Ramirez, A., Bucchia, M., Rinchetti, P., Rideout, H., Papadimitriou, D., Re, D. B., & Corti, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2106-9 · Cited by 71
Hensel, N., Kubinski, S., & Claus, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00045 · Cited by 79
Bhinge, A., Namboori, S. C., Bithell, A., Soldati, C., Buckley, N. J., & Stanton, L. W. (2016) · Stem Cells · doi:10.1002/stem.2233 · Cited by 71
Drug treatment for spinal muscular atrophy types II and III
Wadman, R. I., van der Pol, W. L., Bosboom, W. M., Asselman, F., van den Berg, L. H., Iannaccone, S. T., & Vrancken, A. F. J. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006282.pub5 · Cited by 79
Dombert, B., Sivadasan, R., Simon, C. M., Jablonka, S., & Sendtner, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110846 · Cited by 78
Kichula, E. A., Proud, C. M., Farrar, M. A., Kwon, J. M., Saito, K., Desguerre, I., & McMillan, H. J. (2021) · Muscle & Nerve · doi:10.1002/mus.27363 · Cited by 77
Mouse models of SMA: tools for disease characterization and therapeutic development
Bebee, T. W., Dominguez, C. E., & Chandler, D. S. (2012) · Human Genetics · doi:10.1007/s00439-012-1171-5 · Cited by 77
mRNP assembly, axonal transport, and local translation in neurodegenerative diseases
Khalil, B., Morderer, D., Price, P. L., Liu, F., & Rossoll, W. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.018 · Cited by 65
RNA-binding proteins and translational regulation in axons and growth cones
Hörnberg, H., & Holt, C. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00081 · Cited by 66
The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy
Ahmad, S., Wang, Y., Shaik, G. M., Burghes, A. H. M., & Gangwani, L. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds102 · Cited by 75
Self-citationNeural Circuits Underlying Fly Larval Locomotion
Kohsaka, H., Guertin, P. A., & Nose, A. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161208120835 · Cited by 75
Genetic inhibition of JNK3 ameliorates spinal muscular atrophy
Genabai, N. K., Ahmad, S., Zhang, Z., Jiang, X., Gabaldon, C. A., & Gangwani, L. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv401 · Cited by 74
Arnold, E. S., & Fischbeck, K. H. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00038-7 · Cited by 73
Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm
Gerbino, V., Carrì, M. T., Cozzolino, M., & Achsel, T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.003 · Cited by 73
Xu, X., & Zhong, Z. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.63 · Cited by 73
Aslesh, T., & Yokota, T. (2022) · Cells · doi:10.3390/cells11030417 · Cited by 72
Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model
Valsecchi, V., Boido, M., Amicis, E. D., Piras, A., & Vercelli, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128560 · Cited by 71
Han, K.-J., Foster, D. G., Zhang, N., Kavdia, K., Dzieciątkowska, M., Sclafani, R. A., Hansen, K. C., Peng, J., & Liu, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372318 · Cited by 71
ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy
Kannan, A., Jiang, X., He, L., Ahmad, S., & Gangwani, L. (2019) · Brain · doi:10.1093/brain/awz373 · Cited by 71
Monani, U. R., & Vivo, D. C. D. (2013) · Future Neurology · doi:10.2217/fnl.13.58 · Cited by 70
Feng, Z., Ling, K., Zhao, X., Zhou, C., Karp, G. M., Welch, E. M., Naryshkin, N. A., Ratni, H., Chen, K. S., Metzger, F., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv629 · Cited by 70
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
García-López, A., Tessaro, F., Jonker, H. R. A., Wacker, A., Richter, C. P., Comte, A., Berntenis, N., Schmucki, R., Hatje, K., Petermann, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04110-1 · Cited by 70
McGovern, V. L., Iyer, C. C., Arnold, W. D., Gombash, S. E., Zaworski, P. G., Blatnik, A. J., Foust, K. D., & Burghes, A. H. M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv283 · Cited by 69
Self-citationGrice, S. J., & Liu, J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002030 · Cited by 68
Reconstitution of the human U snRNP assembly machinery reveals stepwise Sm protein organization
Neuenkirchen, N., Englbrecht, C., Ohmer, J., Ziegenhals, T., Chari, A., & Fischer, U. (2015) · The EMBO Journal · doi:10.15252/embj.201490350 · Cited by 67
Tseng, Y., Chen, C., Jong, Y., Chang, F., & Lo, Y. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.023 · Cited by 66
Simon, C. M., Alstyne, M. V., Lotti, F., Bianchetti, E., Tisdale, S., Watterson, D. M., Mentis, G. Z., & Pellizzoni, L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.058 · Cited by 66
Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model
Singh, N. N., & Singh, R. N. (2011) · RNA Biology · doi:10.4161/rna.8.4.16224 · Cited by 65
SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice
Gombash, S. E., Cowley, C. J., Fitzgerald, J. A., Iyer, C. C., Fried, D. E., McGovern, V. L., Williams, K. C., Burghes, A. H. M., Christofi, F. L., Gulbransen, B. D., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv127 · Cited by 65
Self-citationNizzardo, M., Nardini, M., Ronchi, D., Salani, S., Donadoni, C., Fortunato, F., Colciago, G., Falcone, M., Simone, C., Riboldi, G., et al. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.01.017 · Cited by 64
Thomas, W. B. (2010) · Frontiers in bioscience · doi:10.2741/3670 · Cited by 65
Little, D., Valori, C. F., Mutsaers, C. A., Bennett, E., Wyles, M., Sharrack, B., Shaw, P. J., Gillingwater, T. H., Azzouz, M., & Ning, K. (2014) · Molecular Therapy · doi:10.1038/mt.2014.209 · Cited by 64
He, J., Zhang, Q., Lin, Q., Chen, Y., Lin, X., Lin, M.-T., Murong, S.-X., Wang, N., & Chen, W. (2013) · Gene · doi:10.1016/j.gene.2012.12.109 · Cited by 64
Drug treatment for spinal muscular atrophy type I
Wadman, R. I., Bosboom, W. M., van der Pol, W. L., van den Berg, L. H., Wokke, J. H. J., Iannaccone, S. T., & Vrancken, A. F. J. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006281.pub4 · Cited by 64
Armbruster, N., Lattanzi, A., Jeavons, M., Van Wittenberghe, L., Gjata, B., Marais, T., Martin, S., Vignaud, A., Voit, T., Mavilio, F., et al. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.60 · Cited by 54
Rac1 at the crossroad of actin dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis
D’Ambrosi, N., Rossi, S., Gerbino, V., & Cozzolino, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00279 · Cited by 53
R-Loops in Motor Neuron Diseases
Perego, M. G. L., Taiana, M. M., Bresolin, N., Comi, G. P., & Corti, S. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1246-y · Cited by 63
Lugin, M. L., Lee, R. T., & Kwon, Y. J. (2020) · ACS Nano · doi:10.1021/acsnano.0c03850 · Cited by 63
Tapia, O., Bengoechea, R., Palanca, A., Arteaga, R., Val‐Bernal, J. F., Tizzano, E. F., Berciano, M. T., & Lafarga, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0921-8 · Cited by 62
Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease
Roake, C. M., Chen, L., Chakravarthy, A. L., Ferrell, J. E., Raffa, G. D., & Artandi, S. E. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.033 · Cited by 62
Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy
Butchbach, M. E. R., Rose, F. F., Rhoades, S. J., Marston, J. A., McCrone, J. T., Sinnott, R., & Lorson, C. L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.148 · Cited by 62
Molecular mechanisms and animal models of spinal muscular atrophy
Edens, B. M., Ajroud‐Driss, S., Ma, L., & Ma, Y. C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.024 · Cited by 61
Lafarga, M., Tapia, O., Romero, A. M., & Berciano, M. T. (2016) · RNA Biology · doi:10.1080/15476286.2016.1231360 · Cited by 61
Metadata
- Authors
- Burghes, A. H. M., & Beattie, C. E.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Burghes, Arthur H. M.
- Venue
- Nature Reviews Neuroscience
- Published
- 2009-07-08
- Volume
- 10
- Issue
- 8
- Pages
- 597-609
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC2853768
- OpenAlex
- W2148071380
- Cited by
- 723
- References
- 176
- Citations by year
- 2026: 24 · 2025: 27 · 2024: 28 · 2023: 33 · 2022: 33 · 2021: 41 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 54 · 2016: 50 · 2015: 50 · 2014: 46 · 2013: 56 · 2012: 43
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS038650, R01NS041649)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- spinal muscular atrophy, survival motor neuron protein, SMN1, motor neuron dysfunction, small nuclear ribonucleoproteins, pre-mRNA splicing, ribonucleoprotein assembly, mRNA transport, loss-of-function mutations, neurodegeneration
- MeSH terms
- Humans, Models, Biological, Motor Neurons, Muscular Atrophy, Spinal, Ribonucleoproteins, Small Nuclear, Survival of Motor Neuron 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.